Form 4: Director Neil Desai Receives Stock Options in Whitehawk
Statement of Changes in Beneficial Ownership
Director Neil Desai was granted 38,040 stock options in Whitehawk Therapeutics, Inc. as part of an equity incentive plan.
Summary
- Director Neil Desai acquired 38,040 stock options in Whitehawk Therapeutics, Inc. (WHWK).
- The options have an exercise price of $4.16 per share.
- The grant date for these options is June 12, 2026.
- The options are set to expire on June 12, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential for future dilution of existing shareholders upon the exercise of these options.
Risks
- Vesting is contingent upon the reporting person remaining a Service Provider through the vesting date.
Future Outlook
The options vest 100% on the earlier of the one-year anniversary of the grant date or the day prior to the next annual meeting of stockholders.
Management Comments
- The grant is subject to the Reporting Person continuing to be a Service Provider as defined in the Issuer's 2021 Equity Incentive Plan.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practice to ensure leadership remains incentivized to drive company performance and align with shareholder interests.
Comparison to Industry Standards
- The use of a one-year vesting schedule is consistent with standard equity incentive practices for non-employee directors in the biotechnology and pharmaceutical sectors.
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- Vesting of options on the earlier of June 12, 2027, or the day prior to the next annual meeting.
Key Dates
| Date | Description |
|---|---|
| 06/12/2026 | Date of grant and earliest transaction date for the stock options. |
| 06/12/2036 | Expiration date of the granted stock options. |
| 06/15/2026 | Date the Form 4 was signed and filed. |
Keywords
Whitehawk Therapeutics, WHWK, Form 4, Insider Trading, Stock Options, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.